Although mesenchymal stem cell therapies show promising symptom relief and preclinical regenerative potential, their ability to successfully regrow damaged articular and hyaline cartilage in human joints remains clinically contested and often confounded by concurrent surgical procedures.
Mesenchymal stem cell injections show promising preclinical and some clinical potential for cartilage repair, though human joint regeneration remains contested and often confounded by concurrent surgeries.